Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about MKKGY

Recent news which mentions MKKGY

WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
Tickers AXSM CRSP GDS MKGAF
Tags GDS WGS Equities
From Benzinga
Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics
Tickers MKGAF MKKGY NEWS SWTX
Tags News Top Stories MKKGY
From Benzinga
GSK To Buy US-Based Stomach Cancer Drug Developer For Over $1 Billion
Tickers GSK MKGAF MKKGY NEWS
Tags News MKKGY Top Stories
From Benzinga
Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition
Tickers MKKGY PFE SGEN
Tags M&A Biotech Equities
From Benzinga
Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
Tickers MKGAF MKKGY SNY
Tags Biotech SNY Benzinga
From Benzinga
Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors
Tickers MKGAF MKKGY RGEN
Tags MKKGY Expert Ideas Analyst Color
From Benzinga
Merck Germany Reports 5% Decline In Q2 Sales, Expects More Decline In 2023
Tickers MKGAF MKKGY
Tags Guidance News MKKGY
From Benzinga
Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
Tickers MKGAF MKKGY NVO REGN
Tags News MKKGY REGN
From Benzinga
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
Tickers A ABCM DHR MKGAF
Tags A Analyst Ratings MKGAF
From Benzinga
Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions
Tickers LLY MKGAF MKKGY NKTR
Tags Market News General Briefs
From Benzinga
FDA Issues Partial Clinical Hold On Merck Germany's Multiple Sclerosis Study
Tickers MKGAF MKKGY
Tags News MKKGY Biotech
From Benzinga
Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer
Tickers M MKGAF MKKGY PFE
Tags MKKGY News Large Cap
From Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
Tickers INCY MGNX MKGAF MKKGY
Tags News Small Cap MKKGY
From Benzinga
With Upcoming Ovarian Cancer Data, Analyst Sees 100% Upside For Mersana Therapeutics
Tickers MKKGY MRSN
Tags Biotech Analyst Ratings MRSN
From Benzinga
PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment
Tickers MKGAF MKKGY PDSB
Tags PDSB Briefs General
From Benzinga
Mersana Inks Cancer Therapy Development Deal With Merck Germany
Tickers MKGAF MKKGY MRSN
Tags Market News General Briefs
From Benzinga
SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19
Tickers AAPL ABT ACI AMZN
Tags ZEN Small Cap Rumors
From Benzinga
Germany's Merck Slapped With Formal French Investigation Related To Its Thyroid Drug
Tickers MKKGY
Tags Benzinga Market News General
From Benzinga
PDS Biotech Highlights Expanded Data From PDS0101 Triple Combination Trial In HPV-Positive Cancers
Tickers MKKGY MRK PDSB
Tags Biotech Trading Ideas Benzinga
From Benzinga
Here's How Day One Biopharmaceuticals Stock Could Keep Climbing
Tickers DAWN MKKGY
Tags Recent Press Releases MKKGY DAWN
From Motley Fool
Germany's Merck To Launch Semiconductor Base In China
Tickers MKKGY TECH
Tags Media MKKGY News
From Benzinga
Wall Street Thinks Palantir Is Poised for a Comeback. Here's Why
Tickers MKKGY PIPR PLTR
Tags PIPR PLTR MKKGY
From Motley Fool
Cathie Wood Can't Get Enough of These 2 Biotech Stocks
Tickers ADPT ARKG BNR MKKGY
Tags ARKG MKKGY Recent Press Releases
From Motley Fool
TSM Looks To Hire Over 8,000 People In 2022
Tickers ASML ENTG MDTKF MKKGY
Tags Media QCOM MKKGY
From Benzinga
Despite Palantir’s Impressive Deals, Its Losses and Valuation Make It Unappetizing
Tickers MKKGY PLTR
Tags PLTR MKKGY Stocks to Sell
From InvestorPlace
The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
Tickers AZN BNR BNTX CBAY
Tags CVAC GSK News
From Benzinga
GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact
Tickers GSK MKGAF MKKGY MRK
Tags Biotech lung cancer MRK
From Benzinga
Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study
Tickers MKGAF MKKGY NKTR PFE
Tags MKKGY bladder cancer News
From Benzinga
Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial
Tickers GSK MKGAF MKKGY MRK
Tags News Biotech MKKGY
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.